Skip to main content
. 2021 Sep 22;9(11):e1539–e1552. doi: 10.1016/S2214-109X(21)00340-5

Figure 1.

Figure 1

Model diagram

Individual level data from survey respondents with diabetes mellitus in the WHO STEPwise approach to Surveillance and attendant surveys (2006–18)12 were used to estimate the baseline risk of macrovascular and microvascular complications of diabetes. Data from randomised controlled trials were then used to estimate the effect of increased blood pressure, glycaemia, and statin treatment, and increased blood pressure and glucose control, with or without new screening to increase the overall rates of diagnosis of diabetes and hypertension.